Improvements in MADRS total score , CGI-S , CGI-I , and HAMD in the olanzapine group were significantly greater relative to those in the placebo group during the 8-week follow-up period ( p < 0.001 , p = 0.0017 , p = 0.007 , and p < 0.001 , respectively ) .